These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

77 related articles for article (PubMed ID: 11563814)

  • 1. Circulating soluble tumor necrosis factor receptor as a marker for diagnosis of pulmonary embolus.
    Taheri SA; Shenoy SS; Mousa S
    J Med; 2001; 32(3-4):163-8. PubMed ID: 11563814
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prolonged activation of tumor necrosis factor (TNF)-alpha and its soluble receptors in chronic heart failure patients both in the compensated and decompensated state. Interplay between their levels and metalloproteinase-3.
    Tziakas D; Chalikias G; Parissis JT; Hatzinikolaou H; Stakos D; Papadopoulou E; Kortsaris A; Hatseras D
    Eur Cytokine Netw; 2004; 15(3):231-9. PubMed ID: 15542448
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Soluble tumor necrosis factor receptor II and soluble cell adhesion molecule 1 as markers of tumor necrosis factor-alpha release in preeclampsia.
    Visser W; Beckmann I; Knook MA; Wallenburg HC
    Acta Obstet Gynecol Scand; 2002 Aug; 81(8):713-9. PubMed ID: 12174154
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Value of ischemia-modified albumin in the diagnosis of pulmonary embolism.
    Turedi S; Gunduz A; Mentese A; Karahan SC; Yilmaz SE; Eroglu O; Nuhoglu I; Turan I; Topbas M
    Am J Emerg Med; 2007 Sep; 25(7):770-3. PubMed ID: 17870479
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Activity of Tumor Necrosis Factor-alpha (TNF-alpha) and its soluble type I receptor (p55TNF-R) in some drug-induced cutaneous reactions.
    Chodorowska G; Czelej D; Niewiedzioł M
    Ann Univ Mariae Curie Sklodowska Med; 2003; 58(2):50-6. PubMed ID: 15323166
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diagnosis of deep venous thrombosis by use of soluble necrosis factor receptor.
    Taheri SA; Lazar L; Haddad G; Castaldo R; Wilson M; Mousa S
    Angiology; 1998 Jul; 49(7):537-41. PubMed ID: 9671852
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Titer of tumor necrosis factor receptor: can it be a predictor of the development of deep vein thrombosis and pulmonary embolism?
    Hirose H
    Angiology; 1999 Jan; 50(1):85-6. PubMed ID: 9924894
    [No Abstract]   [Full Text] [Related]  

  • 8. Plasma levels of tumor necrosis factor alpha and soluble tumor necrosis factor receptors in patients with narcolepsy.
    Himmerich H; Beitinger PA; Fulda S; Wehrle R; Linseisen J; Wolfram G; Himmerich S; Gedrich K; Wetter TC; Pollmächer T
    Arch Intern Med; 2006 Sep; 166(16):1739-43. PubMed ID: 16983052
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Tumor necrosis factor alpha and its soluble receptors in serum of patients with coronary artery disease].
    Mizia-Stec K; Mandecki T; Zahorska-Markiewicz B; Janowska J; Szulc A; Jastrzebska-Maj E; Szymański L
    Pol Merkur Lekarski; 2001 Jul; 11(61):19-25. PubMed ID: 11579824
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Circadian fluctuations of melatonin, tumor necrosis factor-alpha and its soluble receptors in the circulation of patients with advanced gastrointestinal cancer.
    Muc-Wierzgon M; Nowakowska-Zajdel E; Zubelewicz B; Wierzgon J; Kokot T; Klakla K; Szkilnik R; Wiczkowski A
    J Exp Clin Cancer Res; 2003 Jun; 22(2):171-8. PubMed ID: 12866566
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Elevated triglycerides and low levels of high-density lipoprotein as markers of disease activity in association with up-regulation of the tumor necrosis factor alpha/tumor necrosis factor receptor system in systemic lupus erythematosus.
    Svenungsson E; Gunnarsson I; Fei GZ; Lundberg IE; Klareskog L; Frostegård J
    Arthritis Rheum; 2003 Sep; 48(9):2533-40. PubMed ID: 13130473
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tumor necrosis factor receptors (TNFRs) on T lymphocytes and soluble TNFRs in different clinical courses of sarcoidosis.
    Kieszko R; Krawczyk P; Chocholska S; Bojarska-Junak A; Jankowska O; Król A; Roliński J; Milanowski J
    Respir Med; 2007 Mar; 101(3):645-54. PubMed ID: 16889950
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Analysis of tumor necrosis factor-alpha, interleukin-6, interleukin-1beta, soluble tumor necrosis factor receptors I and II, interleukin-6 soluble receptor, interleukin-1 soluble receptor type II, interleukin-1 receptor antagonist, and protein in the synovial fluid of patients with temporomandibular joint disorders.
    Kaneyama K; Segami N; Sun W; Sato J; Fujimura K
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2005 Mar; 99(3):276-84. PubMed ID: 15716832
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serum neopterin, tumor necrosis factor-alpha and soluble tumor necrosis factor receptor II (p75) levels and disease activity in Egyptian female patients with systemic lupus erythematosus.
    Mahmoud RA; El-Gendi HI; Ahmed HH
    Clin Biochem; 2005 Feb; 38(2):134-41. PubMed ID: 15642275
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serum cytokine and soluble cytokine receptor levels in patients with non-alcoholic steatohepatitis.
    Abiru S; Migita K; Maeda Y; Daikoku M; Ito M; Ohata K; Nagaoka S; Matsumoto T; Takii Y; Kusumoto K; Nakamura M; Komori A; Yano K; Yatsuhashi H; Eguchi K; Ishibashi H
    Liver Int; 2006 Feb; 26(1):39-45. PubMed ID: 16420507
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic value of circulating chromogranin A and soluble tumor necrosis factor receptors in advanced nonsmall cell lung cancer.
    Gregorc V; Spreafico A; Floriani I; Colombo B; Ludovini V; Pistola L; Bellezza G; Viganò MG; Villa E; Corti A
    Cancer; 2007 Aug; 110(4):845-53. PubMed ID: 17599769
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association between early detection of soluble TNF-receptors and mortality in burn patients.
    Ribeiro CA; Andrade C; Polanczyk CA; Clausell N
    Intensive Care Med; 2002 Apr; 28(4):472-8. PubMed ID: 11967603
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tumour necrosis factor receptors (TNFRs) in Type 2 diabetes. Analysis of soluble plasma fractions and genetic variations of TNFR2 gene in a case-control study.
    Vendrell J; Broch M; Fernandez-Real JM; Gutiérrez C; Simón I; Megia A; Gallart L; Ricart W; Richart C
    Diabet Med; 2005 Apr; 22(4):387-92. PubMed ID: 15787661
    [TBL] [Abstract][Full Text] [Related]  

  • 19. No association between serum levels of tumor necrosis factor-alpha (TNF-alpha) or the soluble receptors sTNFR1 and sTNFR2 and breast cancer risk.
    Krajcik RA; Massardo S; Orentreich N
    Cancer Epidemiol Biomarkers Prev; 2003 Sep; 12(9):945-6. PubMed ID: 14504210
    [No Abstract]   [Full Text] [Related]  

  • 20. Plasma levels of tumor necrotic factor-alpha and interleukin-6, -8 during orthotopic liver transplantation and their relations to postoperative pulmonary complications.
    Wen XH; Kong HY; Zhu SM; Xu JH; Huang SQ; Chen QL
    Hepatobiliary Pancreat Dis Int; 2004 Feb; 3(1):38-41. PubMed ID: 14969835
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.